BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22934694)

  • 1. Functional nanoplatforms for enhancement of chemotherapeutic index.
    Yang J; Lee E; Ku M; Huh YM; Cheong JH
    Anticancer Agents Med Chem; 2013 Feb; 13(2):212-21. PubMed ID: 22934694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug nanocarriers and functional nanoparticles: applications in cancer therapy.
    Thierry B
    Curr Drug Deliv; 2009 Aug; 6(4):391-403. PubMed ID: 19534706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Based Combination Therapy for Cancer Treatment.
    Yhee JY; Son S; Lee H; Kim K
    Curr Pharm Des; 2015; 21(22):3158-66. PubMed ID: 26027570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
    Liboiron BD; Mayer LD
    Ther Deliv; 2014 Feb; 5(2):149-71. PubMed ID: 24483194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
    Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
    Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells.
    Kaur L; Sohal HS; Kaur M; Malhi DS; Garg S
    Anticancer Agents Med Chem; 2020; 20(17):2012-2024. PubMed ID: 32753024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer.
    Naz S; Shamoon M; Wang R; Zhang L; Zhou J; Chen J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy.
    Lin H; Chen Y; Shi J
    Chem Soc Rev; 2018 Mar; 47(6):1938-1958. PubMed ID: 29417106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches.
    Beheshtizadeh N; Amiri Z; Tabatabaei SZ; Seraji AA; Gharibshahian M; Nadi A; Saeinasab M; Sefat F; Kolahi Azar H
    J Transl Med; 2024 May; 22(1):520. PubMed ID: 38816723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumventing tumor resistance to chemotherapy by nanotechnology.
    Liang XJ; Chen C; Zhao Y; Wang PC
    Methods Mol Biol; 2010; 596():467-88. PubMed ID: 19949937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances toward More Efficient Targeted Delivery of Nanoparticles in Vivo: Understanding Interactions between Nanoparticles and Cells.
    Polo E; Collado M; Pelaz B; Del Pino P
    ACS Nano; 2017 Mar; 11(3):2397-2402. PubMed ID: 28267316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery.
    Gou M; Wei X; Men K; Wang B; Luo F; Zhao X; Wei Y; Qian Z
    Curr Drug Targets; 2011 Jul; 12(8):1131-50. PubMed ID: 21443476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents.
    Joshi N; Kaur S; Banerjee R
    Curr Pharm Des; 2016; 22(17):2470-80. PubMed ID: 26915832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based immunotherapies to combat cancer metastasis.
    Zhao Y; Bilal M; Qindeel M; Khan MI; Dhama K; Iqbal HMN
    Mol Biol Rep; 2021 Sep; 48(9):6563-6580. PubMed ID: 34424444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.